Shilajit and the Pill: What You Should Know About Possible Interactions
Leila WehrhahnUpdated:The most important points at a glance:
There are no direct human studies on shilajit and the contraceptive pill. A theoretical influence has been discussed via CYP3A4, transporters and the enterohepatic circulation, but supporting evidence is lacking. There are currently no specific indications of reduced contraceptive effectiveness. Exercise caution: seek medical advice when starting, stopping or changing the dose of shilajit. Watch out for breakthrough bleeding. Use only tested, quality-controlled products. If you experience vomiting or severe diarrhoea, consider additional contraceptive protection.
Shilajit & the pill – why this topic matters
Many women use hormonal contraception (e.g. combination pills with ethinylestradiol and progestogens). At the same time, interest in natural supplements such as Shilajit is increasing. The central question is: Does Shilajit affect how well the pill works? At present, there are no direct clinical studies that demonstrate or reliably rule out an interaction (1). Caution is still advisable, as known mechanisms with herbal products (e.g. enzyme induction) could theoretically be relevant (2).
The aim here is to present the current state of knowledge in an accessible way: What is Shilajit? Which interaction mechanisms are generally relevant for hormonal contraceptives? Where are the gaps in the data and how can you proceed cautiously in everyday use?
There are no direct studies on Shilajit and the pill. Theoretical risks via enzyme pathways are conceivable. Act cautiously and seek medical advice.
What is Shilajit?
Shilajit is a herbo-mineral natural resin from high mountain regions, rich in fulvic and humic acids as well as minerals (e.g. zinc, magnesium, selenium). Traditionally it has been used to support energy and recovery; modern investigations describe antioxidant and adaptogenic properties (3). You can find more about its general profile in our article Shilajit effects.
For the question “Shilajit & the pill”, the key issue is whether ingredients influence the metabolism of pill ingredients (typically CYP3A4-dependent) or disrupt the enterohepatic circulation. No robust human data are currently available on this (1). Accordingly, data are lacking and further studies are needed to assess safety and interaction potential more clearly.
What does the evidence say about oral contraceptives (OC)?
At present, there are no direct human studies that have examined the interaction between Shilajit and combination pills (e.g. ethinylestradiol/levonorgestrel) from a pharmacokinetic or clinical perspective (1). In commonly used interaction overviews Shilajit is not listed as a confirmed interaction partner; at the same time, the data are very limited overall (2). Case reports of “pill failure while taking Shilajit” have not been published to date (3).
What is known: many OC substances are metabolised via CYP3A4 and can also be influenced by transporters such as P-glycoprotein. Potent enzyme inducers (e.g. certain antituberculosis medicines) can lower OC levels and may compromise contraceptive effectiveness – there is currently no evidence of this in relation to Shilajit (1)(2). Until robust studies are available, a cautious approach and medical consultation are recommended, particularly when starting, stopping or changing the dose of Shilajit (4). Further information on general interactions can be found in Shilajit interactions.
Possible mechanisms & plausibility
Shilajit is a complex herbo-mineral mixture (including fulvic/humic acids). Theoretically relevant pathways for OCs would include:
- CYP3A4 and other CYP isoenzymes: Induction or inhibition could alter OC levels – this has not been demonstrated for Shilajit (1)(2).
- Transporters (P-gp): Changes in intestinal absorption are conceivable, but not shown (1).
- Enterohepatic circulation of ethinylestradiol: Disruption (e.g. due to pronounced diarrhoea) could theoretically reduce EE levels; there are no specific data on Shilajit regarding this (3).
- SHBG levels / hormone binding: Data showing that Shilajit changes sex hormone-binding globulin or OC hormone levels are lacking (3).
- Quality & purity: Impure products (heavy metals, contaminants) carry their own risks, but are not a documented OC interaction mechanism – they do, however, underline the importance of using products tested with a certificate of analysis (CoA) (4).
Important: “No data” does not automatically mean “no risk”. Until robust studies (PK/PD, clinical endpoints) are available, it may be sensible to pay attention to signs such as breakthrough bleeding when starting or stopping Shilajit and to seek medical advice if you are unsure. More detailed safety information can also be found in Shilajit side effects.
No OC interactions have been demonstrated for Shilajit. Theoretical pathways (CYP3A4, P-gp, EE circulation) are plausible, but unproven. Until data are available: proceed with caution.

Shilajit Capsules
Practical use: caution & monitoring
As there are no direct human data on Shilajit and oral contraceptives (OC) (1), a careful approach is advisable in practice:
- Before starting/when stopping Shilajit: Seek medical advice; watch for breakthrough bleeding and changes in your cycle (4).
- Changing the dose: Try to ensure changes to Shilajit (start, stop, increase) do not occur at the same time as changes to OC products; monitor bleeding patterns.
- Gastrointestinal events: More pronounced diarrhoea/vomiting may affect how the pill is absorbed – if vomiting occurs shortly after taking the OC, consider using additional protection in line with standard guidance (3).
- Concomitant medication: Check for known OC interactions (e.g. CYP3A4 inducers); for Shilajit this has not been demonstrated, but data are missing (1)(2). See also Shilajit interactions.
- Warning signs: Persistent spotting/breakthrough bleeding, cycle changes or typical hormonal symptoms should be checked by a healthcare professional.
Important: “No data” ≠ “no risk”. Until robust studies are available, a cautious approach with monitoring is reasonable (1)(4).
Safety & quality
Studies with purified, laboratory-tested Shilajit preparations report good tolerability; mild gastrointestinal complaints are occasionally described (3). For the specific question “Shilajit & the pill”, however, direct safety data are lacking (1).
- Only tested products: Certificate of analysis (CoA), tested for heavy metals, microbiological quality, clear origin/standardisation (fulvic acid) (3).
- Conservative dosing: Base intake on doses commonly used in studies and avoid high-dose self-experiments without medical supervision.
- Individual factors: Consider comorbidities, multiple medicines and hormonal sensitivity; seek medical advice if in doubt (4).
- Monitoring side effects: If new gastrointestinal symptoms, skin reactions or cycle changes occur, review your use. Additional information: Shilajit side effects.
Purified Shilajit is generally considered well tolerated, but direct data on use with the pill are lacking. Use only CoA-tested products, dose conservatively and watch for warning signs.
Dosage & use
For general purposes, studies often use 250–500 mg Shilajit per day, sometimes split into several doses. As there are no specific human data on the combination “Shilajit & the pill” (1), a conservative start (e.g. the lowest effective dose) and taking it with a meal for better tolerability may be considered (3).
- Quality first: Use only laboratory-tested, purified products with a CoA (fulvic acid standardisation, heavy metals/microbiology tested) (3). You can read more about potential side effects in Shilajit side effects.
- Timing & monitoring: Try not to start/stop or change the dose of Shilajit at the same time as switching OC products; watch for breakthrough bleeding and cycle patterns (4).
- Individual advice: With multiple medicines or pre-existing conditions, seek medical advice (2)(4). General information on interactions can also be found under Shilajit interactions.
For practical everyday use, Shilajit capsules can be convenient. However, as there are no robust data on the combination with OCs, medical consultation before starting is advisable (1)(4).
Conclusion
There are currently no direct clinical data indicating that Shilajit reduces the effectiveness of oral contraceptives (1). At the same time, robust PK/PD studies on relevant mechanisms (e.g. CYP3A4, P-gp, enterohepatic circulation) are missing (2)(3). Until such data are available, a careful approach with monitoring (breakthrough bleeding, cycle changes) and medical advice, particularly when starting/stopping/changing the dose, is recommended (4).
When used in appropriate quality, Shilajit may be considered as a complementary option for general wellbeing. For the specific question “Shilajit & the pill”, however, further, well-designed studies are needed to clarify the benefit–risk balance and any interactions (1)(2).
No firm data are available on Shilajit & the pill: theoretical interactions are possible, but unproven. Proceed with caution, watch for signals and seek medical advice.
